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Abstract: T cell-mediated autoimmune diseases such as multiple sclerosis and rheumatoid arthritis are
driven by autoaggressive Th cells. The pathogenicity of such Th cells has, in the past, been considered to
be dictated by their cytokine polarization profile. The polarization of such effector T cells relies critically
upon the actions of cytokines secreted by APCs. While Th1 polarization has long been associated with
the pathogenesis of autoimmune diseases, recent data obtained in gene-targeted mice and the discovery
of Th17 cell involvement in autoimmunity conflict with this hypothesis. In light of these recent develop-
ments, we discuss in this review the actions of APC-derived cytokines and their emerging roles in T cell
polarization in the context of autoimmune inflammatory responses.
DOI: 10.1172/JCI31720




Gutcher, I; Becher, B (2007). APC-derived cytokines and T cell polarization in autoimmune inflamma-
tion. Journal of Clinical Investigation, 117(5):1119-1127. DOI: 10.1172/JCI31720
Science in medicine












































































APC-derived cytokines and T cell polarization  
in autoimmune inflammation
Ilona Gutcher and Burkhard Becher
















































































































Within the immune synapse formed between APCs and T cells, three 
signals are required for antigen-specific T cell activation. Signal 1 com-
prises the presentation of antigen peptide, in the context of MHC class II 
molecules, which is recognized by the antigen-specific TCR. Signal 2 
involves the stabilization of the synapse through adhesion molecules 
and the generation of signals via costimulatory molecules present on 
the surface of APCs and T cells. CD80/CD86 on APCs interact with their 
receptor, CD28, on T cells to generate activatory signals, while interac-
tion with cytotoxic T lymphocyte–associated protein 4 (CTLA4) gener-
ates inhibitory signals (not shown). Signal 3 is produced by the secretion 
of cytokines by APCs, which signal via cytokine receptors on T cells in 
order to polarize them toward an effector phenotype. Ag, antigen.
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Evidence for Th1 pathogenesis in autoimmunity).





























































MBP, myelin basic protein; rhIL-18BP, recombinant human IL-18 binding protein; RR-MS, relapsing-remitting MS. ↑, increased; ↓, decrease(d).
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APC-derived cytokines guide the differentiation of naive T cells into 
an effector T cell subtype. Secretion of IL-12, in synergy with IL-18, 
leads to the generation of Th1 cells. Initial IL-12 production directs the 
upregulation of IL-18R and IL-12Rβ2 expression on the surface of Th1 
precursor (Th1p) cells that allows IL-18 to aid IL-12 in Th1 polarization. 
TGF-β secretion can polarize naive cells toward a regulatory pheno-
type or an autoaggressive phenotype, depending on the cytokine envi-
ronment: secretion of TGF-β alone by APCs supports Treg formation 
(which counteracts autoimmune inflammation) from Treg precursor 
cells (Treg-p cells). However, the additional presence of IL-6 results 
in the production of Th17 cells, which are now considered to be the 
pathogenic T cell population during autoimmunity. The pathogenic, 
APC-derived cytokine IL-23 is critical for the maintenance and survival 
of these autoreactive Th17 cells. The interaction of APCs and Th2 
precursor (Th2p) cells in the absence of IL-12 and IL-18 induces the 
production of the Th2 cytokine IL-4 by T cells, which acts in an auto-
crine fashion to polarize committed Th2 cells.
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Evidence for Th17 pathogenesis in autoimmunity).
IL-18: another Th1 inducer lost to autoimmune pathology
The evidence discussed above clearly argues against a role for IFN-γ– 
secreting Th1 cells in the pathogenesis of autoimmune disease and 



































































EAU, experimental autoimmune uveoretinitis. 
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model:  a  personal  perspective.  Nat. Immunol. 
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